Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous iron for cancer-related anaemia symptoms
ISRCTN13370767Phase 4Completed
- Sponsor
- Nottingham University Hospitals
- Start
- Oct 2018
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01
Overview
Phase 4, randomised, double-blind trial in anaemia comparing Intravenous iron isomaltoside with Placebo normal saline (2 arms). Primary endpoint: Feasibility. Started Oct 2018; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
anaemia
Beyond the preview
Go deeper on ISRCTN13370767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13370767.